LauraKayeAguilarMDPhD

Pediatric Hematology & Oncology • Newton, MA

Chief Medical Officer, Diakonos Oncology

Join to view full profile

Dr. Aguilar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Aguilar's full profile

Already have an account?

Office
440 Lexington St
#450
Newton, MA 02466

Education & Training

Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 1997 - 1999
Baylor College of Medicine (Houston)Residency, Pediatrics, 1994 - 1996
Baylor College of MedicineClass of 1994

Certifications & Licensure

MA State Medical License 2001 - 2025
TX State Medical License 1995 - 2005

Publications & Presentations

PubMed

6 citations
Perturbing DDR signaling enhances cytotoxic effects of local oncolytic virotherapy and modulates the immune environment in glioma.
Marilin S Koch, Mykola Zdioruk, Michal O Nowicki, Alec M Griffith, Estuardo Aguilar-Cordova
Molecular Therapy Oncolytics. 2022-09-15
9 citations
Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models.
Marilin S Koch, Mykola Zdioruk, Michal O Nowicki, Alec M Griffith, Estuardo Aguilar
Journal for Immunotherapy of Cancer. 2022-01-01
41 citations
Leveraging external data in the design and analysis of clinical trials in neuro-oncology.
Rifaquat Rahman, Steffen Ventz, Jon McDunn, Bill Louv, Irmarie Reyes-Rivera
The Lancet. Oncology. 2021-10-01

Press Mentions

Diakonos Oncology Appoints Laura Aguilar, M.D., Ph.D. As Chief Medical OfficerNovember 18th, 2024